From bench to bedside:Molecular mechanisms,diagnostic tools,and therapeutic strategies in liver fibrosisOA
From bench to bedside:Molecular mechanisms,diagnostic tools,and therapeutic strategies in liver fibrosis
Zhen Yang;Weizhao Tong;Kanglong Zhang;Guoxin Hu
Shantou University Medical College,Shantou,Guangdong,China||Department of Infectious Diseases,Peking University Shenzhen Hospital,Shenzhen,Guangdong,ChinaDepartment of Infectious Diseases,Peking University Shenzhen Hospital,Shenzhen,Guangdong,ChinaDepartment of Infectious Diseases,Peking University Shenzhen Hospital,Shenzhen,Guangdong,ChinaDepartment of Infectious Diseases,Peking University Shenzhen Hospital,Shenzhen,Guangdong,China
Liver fibrosisHepatic stellate cells(HSCs)Extracellular matrix(ECM)Oxidative stressNoninvasive diagnosisAntifibrotic therapy
Liver fibrosisHepatic stellate cells(HSCs)Extracellular matrix(ECM)Oxidative stressNoninvasive diagnosisAntifibrotic therapy
《肝脏研究（英文）》 2026 (2)
133-150,18
This work was supported by the Natural Science Foundation of Guangdong Province(No.2023A1515012663),the National Natu-ral Science Foundation of China(No.81473473),the Shenzhen Key Laboratory of Inflammatory and Immunology Diseases(No.ZDSYS20200811143756018),the Shenzhen High-level Hospital Construction Fund,and the Peking University Shenzhen Hospital Scientific Research Fund(No.KYQD2023307).
评论